3646 results for «2301»
3646 results
Multivessel disease or left main disease
22 May 2026 – From EuroPCR 2026
This session explores revascularisation strategies for patients with multivessel or left main coronary artery disease. It emphasizes the role of intravascular physiology and imaging in guiding treatment decisions and highlights procedural factors that contribute to improved long-term clinical outcomes, supported by complex case discussions.
From atherectomy to lithotripsy: choosing the right tool for the right calcium
22 May 2026 – From EuroPCR 2026
Delve into the latest advancements in calcium modification devices and techniques in this session, which guides clinicians through selecting the most appropriate tool based on calcium morphology. Through step-by-step, case-based decision-making, it enhances procedural planning and lesion preparation to optimize interventional outcomes.
INOCA in patients with coronary artery disease
21 May 2026 – From EuroPCR 2026
This session focuses on ischaemia with non-obstructive coronary arteries (INOCA) in patients with coronary artery disease. It raises awareness of common clinical presentations, emphasizes accurate diagnosis through functional coronary testing, and discusses how tailored treatment strategies can improve patient outcomes in this frequently under-recognized condition.
Hybrid percutaneous revascularisation: combining DES and DCB for optimal results
21 May 2026 – From EuroPCR 2026
This session delves into hybrid percutaneous revascularisation techniques that combine drug-eluting stents (DES) and drug-coated balloons (DCB) to achieve optimal clinical results. It highlights the clinical and anatomical scenarios suited for hybrid PCI, provides a step-by-step procedural approach, and discusses the potential benefits of integrating these...
Calcium in the coronary arteries - What could go wrong?
22 May 2026 – From EuroPCR 2026
This session delves into the complexities of treating calcified coronary artery lesions, highlighting strategic selection of PCI approaches, anticipation of potential complications, and agile adaptation of techniques to manage these challenges effectively. Featuring real-world cases from Ireland and the United Kingdom, it provides critical learnings on...
Spectrum of cardiogenic shock
21 May 2026 – From EuroPCR 2026
This session delves into the broad spectrum of cardiogenic shock phenotypes, emphasizing the importance of selecting appropriate left ventricular support tailored to specific clinical scenarios. It offers critical insights into the timing of mechanical circulatory support and revascularisation strategies to optimize patient outcomes.
The pearl of unloading with mechanical circulatory support
21 May 2026 – From EuroPCR 2026
Delve into the critical aspects of mechanical circulatory support in cardiogenic shock, focusing on device selection, assessment of persistent congestion, and the application of unloading tools to improve patient management and outcomes.
Left main complications - Part 1
21 May 2026 – From EuroPCR 2026
Focus on managing complications related to left main coronary interventions, with detailed case analyses addressing procedural pitfalls, iatrogenic dissections, and unexpected imaging challenges.
Challenges for TAVI in bicuspid
22 May 2026 – From EuroPCR 2026
This session addresses the unique challenges encountered during transcatheter aortic valve implantation (TAVI) in patients with bicuspid aortic valves. It covers procedural nuances for type 0 bicuspid valves, risks associated with anomalous coronary anatomy, and complex anatomical considerations such as large annulus and tortuous aorta, culminating...
Asymptomatic high-risk patients: can CT coronary angiography improve our practice?
21 May 2026 – From EuroPCR 2026
This session examines the role of cardiac computed tomography (CT) coronary angiography in improving clinical practice for asymptomatic high-risk patients. It discusses detection of vulnerable plaque features, the importance of inflammation and physiology in risk assessment, and explores individualized treatment pathways including PCI, medical therapy, or...
Beyond coronary arteries: SVG and peripheral interventions
22 May 2026 – From EuroPCR 2026
This session expands focus beyond coronary arteries to cover interventions in saphenous vein grafts (SVG) and peripheral arteries. It reviews long-term clinical outcomes of SVG PCI, real-world data from coronary artery bypass graft interventions, and advances in ultrasound-guided treatments of peripheral artery lesions, including predictors of...
Calcified lesion of distal protected left main - LIVE case
22 May 2026 – From EuroPCR 2026
An 85‑year‑old man with type 2 diabetes mellitus, hypertension, dyslipidemia, peripheral artery disease, COPD, and chronic kidney disease presented with CCS class II angina related to three‑vessel coronary artery disease. He had previously undergone hybrid revascularization, including PCI of the RCA ostium and CABG with LIMA...
Challenges of multivessel disease in ACS
21 May 2026 – From EuroPCR 2026
Dedicated to the challenges of multivessel disease in acute coronary syndrome (ACS), this session explores strategies to identify culprit versus non-culprit lesions and plan multivessel revascularisation using physiology, intravascular imaging, and artificial intelligence. It further discusses the timing considerations for revascularisation, whether ad-hoc or staged, illustrated...
Spotlight - TAVI durability: contemporary evidence and future directions
21 May 2026 – From EuroPCR 2026
Focusing on TAVI durability, this session reviews recent clinical evidence from randomized trials and large registries, examining procedural and device-related factors influencing long-term valve performance. It also discusses challenges in follow-up and implications for future trial designs and device monitoring.
TAVI sub-studies - Beyond the primary endpoint
21 May 2026 – From EuroPCR 2026
This session reviews key sub-studies from major TAVI trials that extend beyond primary endpoints to provide a deeper understanding of valve performance and patient outcomes. It covers comparisons between balloon-expandable and self-expanding valves, long-term real-world data on the Myval valve, echocardiographic outcomes, composite endpoint analyses, and...
Multivessel complications: what can go wrong
21 May 2026 – From EuroPCR 2026
This session highlights complications encountered in multivessel coronary interventions, presenting complex cases such as lost stents, coronary perforations, shaft fractures, early subacute stent thrombosis, and rare triple vessel thrombosis. It emphasizes practical management strategies for these challenging scenarios in contemporary interventional cardiology.
New data on intracoronary imaging-guided interventions
21 May 2026 – From EuroPCR 2026
This session presents new data on intracoronary imaging-guided interventions, comparing outcomes of angiography-derived FFR and IVUS-guided PCI over two years, as well as OCT versus IVUS for intermediate left main stenosis. It further evaluates high-risk non-culprit lesions post-myocardial infarction, the role of coronary lipid burden in...
All you need to know of DAPT in ACS
21 May 2026 – From EuroPCR 2026
This session provides an in-depth review of dual antiplatelet therapy (DAPT) in acute coronary syndrome (ACS), focusing on strategies for safe de-escalation and P2Y12 inhibitor monotherapy to reduce bleeding risk without compromising ischemic protection. It also covers optimizing antithrombotic therapy in patients on oral anticoagulation and...
AI adoption in the cathlab of tomorrow - Risk prediction applications
20 May 2026 – From EuroPCR 2026
This session delves into the adoption of artificial intelligence in the cath lab, focusing on clinically useful risk prediction models for coronary and structural interventions. It covers advanced AI-guided intravascular imaging, machine learning applications for adverse event prediction, and critical evaluation of model validation and clinical...
Complex endovascular and pulmonary interventions
20 May 2026 – From EuroPCR 2026
Explore advances in complex endovascular and pulmonary interventions, including the transformation of interventional labs into intelligent learning ecosystems, innovative approaches to peripheral and coronary CTOs, and novel therapies such as extravascular renal denervation and fixation catheters for acute pulmonary embolism.